HNRG vs. CERE, CNX, HCC, ARCH, METC, AREC, CEIX, DMLP, CLMT, and SPH
Should you be buying Hallador Energy stock or one of its competitors? The main competitors of Hallador Energy include Cerevel Therapeutics (CERE), CNX Resources (CNX), Warrior Met Coal (HCC), Arch Resources (ARCH), Ramaco Resources (METC), American Resources (AREC), CONSOL Energy (CEIX), Dorchester Minerals (DMLP), Calumet Specialty Products Partners (CLMT), and Suburban Propane Partners (SPH).
Cerevel Therapeutics (NASDAQ:CERE) and Hallador Energy (NASDAQ:HNRG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.
In the previous week, Cerevel Therapeutics had 5 more articles in the media than Hallador Energy. MarketBeat recorded 10 mentions for Cerevel Therapeutics and 5 mentions for Hallador Energy. Cerevel Therapeutics' average media sentiment score of 1.11 beat Hallador Energy's score of 0.54 indicating that Hallador Energy is being referred to more favorably in the news media.
Cerevel Therapeutics presently has a consensus target price of $42.67, suggesting a potential upside of 6.61%. Hallador Energy has a consensus target price of $9.00, suggesting a potential upside of 9.22%. Given Cerevel Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Hallador Energy is more favorable than Cerevel Therapeutics.
Hallador Energy received 87 more outperform votes than Cerevel Therapeutics when rated by MarketBeat users. However, 66.52% of users gave Cerevel Therapeutics an outperform vote while only 60.50% of users gave Hallador Energy an outperform vote.
Hallador Energy has higher revenue and earnings than Cerevel Therapeutics.
87.7% of Cerevel Therapeutics shares are owned by institutional investors. Comparatively, 61.4% of Hallador Energy shares are owned by institutional investors. 5.1% of Cerevel Therapeutics shares are owned by company insiders. Comparatively, 32.3% of Hallador Energy shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Hallador Energy has a net margin of 3.79% compared to Hallador Energy's net margin of 0.00%. Cerevel Therapeutics' return on equity of 8.49% beat Hallador Energy's return on equity.
Cerevel Therapeutics has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Comparatively, Hallador Energy has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.
Summary
Hallador Energy beats Cerevel Therapeutics on 10 of the 14 factors compared between the two stocks.
Get Hallador Energy News Delivered to You Automatically
Sign up to receive the latest news and ratings for HNRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HNRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hallador Energy Competitors List
Related Companies and Tools
